Inhibition of the lytic activity of perforin (cytolysin) and of late complement components by proteoglycans

Détails

ID Serval
serval:BIB_E1AEED2CF4B7
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Inhibition of the lytic activity of perforin (cytolysin) and of late complement components by proteoglycans
Périodique
Molecular Immunology
Auteur⸱e⸱s
Tschopp  J., Masson  D.
ISSN
0161-5890 (Print)
Statut éditorial
Publié
Date de publication
09/1987
Volume
24
Numéro
9
Pages
907-13
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Sep
Résumé
The complement components (C6, C7, C8 and C9) implicated in the lysis of target cells and the pore-forming, lytic protein from cytotoxic T-lymphocytes and NK-cells, perforin, contain an amino acid sequence which is highly homologous to a repeat unit identified in the LDL-receptor (Tschopp et al., 1986, Nature, 322, 831-834). The domain of the LDL-receptor, which is thought to interact with a positively charged segment of its ligands apoprotein B and E, is rich in cysteine residues and contains a cluster of negative charges. We show that the negatively charged molecules suramin and glycosaminoglycans, the positively charged peptides protamine and polylysine, all of which are known to abolish binding of LDL to its receptor (Goldstein et al., 1985, A. Rev. cell. Biol., 1, 1-39) inhibit the lytic activities of C6, C7, C8, C9 and perforin. Moreover, these negatively charged molecules are potent inhibitors of cytolytic T-lymphocyte-mediated lysis of target cells, suggesting a functionally crucial role for perforin in cell-mediated cytolysis. We propose that the negatively charged, cysteine-rich domain of these complement proteins and perforin interacts with an as yet unidentified positively charged segment of its ligand in a manner analogous to the LDL-LDL receptor interaction. Homologous cysteine-rich domains in functionally unrelated proteins may therefore be functionally conserved as ideal rigid interaction domains with the conserved cysteine residues as framework. Specificity of the domain for its ligand would be conferred by the non-conserved amino acid residues.
Mots-clé
Cell Line Complement C9/metabolism Complement Inactivator Proteins/*pharmacology Cytotoxicity, Immunologic/*drug effects Electrophoresis, Polyacrylamide Gel Hemolysis/*drug effects Hydrogen-Ion Concentration *Membrane Glycoproteins Membrane Proteins/*antagonists & inhibitors Pore Forming Cytotoxic Proteins Proteoglycans/*pharmacology T-Lymphocytes, Cytotoxic/immunology
Pubmed
Web of science
Création de la notice
24/01/2008 16:18
Dernière modification de la notice
20/08/2019 17:05
Données d'usage